Table 2.
Variables | Hazard Ratio (95% CI) | P Value |
---|---|---|
Age | 1.05 (1.03–1.06) | <0.001 |
Male | 0.65 (0.48–0.87) | 0.004 |
Current smoking | 1.45 (1.09–1.93) | 0.010 |
Alcohol consumption | 0.66 (0.45–0.96) | 0.028 |
Diabetes mellitus | 1.28 (0.96–1.72) | 0.094 |
Hypertension | 1.99 (1.43–2.75) | <0.001 |
Systolic blood pressure | 1.01 (1.01–1.02) | 0.006 |
Low‐density lipoprotein cholesterol | 0.95 (0.82–1.11) | 0.545 |
Glycosylated hemoglobin | 1.17 (1.05–1.30) | 0.004 |
High‐sensitivity C‐reactive protein | 1.06 (1.02–1.10) | 0.003 |
Number of lesion vessels | 1.25 (1.04–1.50) | 0.015 |
Baseline statin use | 0.72 (0.53–0.97) | 0.030 |
NFS | ||
<−1.455 | 1.00 | <0.001 |
≥−1.455 | 2.27 (1.62–3.18) | |
NFS (per 1‐SD) | 1.57 (1.38–1.80)‡ | <0.001 |
FIB‐4 | ||
<1.3 | 1.00 | <0.001 |
≥1.3 | 2.03 (1.59–2.59) | |
FIB‐4 (per 1‐SD) | 1.10 (1.05–1.15) | <0.001 |
BARD | ||
0–1 | 1.00 | <0.001 |
2–4 | 1.92 (1.50–2.39) | |
BARD (per 1‐point) | 1.39 (1.24–1.55) | <0.001 |
AST/ALT ratio | ||
<0.8 | 1.00 | <0.001 |
≥0.8 | 1.91 (1.49–2.44) | |
AST/ALT ratio (per 1‐SD) | 1.18 (1.11–1.25) | 0.001 |
AST indicates aspartate aminotransferase; ALT, alanine aminotransferase; BARD, body mass index, AST/ALT ratio, diabetes mellitus score; FIB‐4, fibrosis‐4; and NFS, nonalcoholic fatty liver disease fibrosis score.